AXL Series: OUD Treatment in the Era of Fentanyl



Date & Location
Tuesday, June 27, 2023, 10:00 AM - Saturday, June 27, 2026, 11:30 AM

Credits
AMA PRA Category 1 Credits™ (1.50 hours), ANCC Nursing Contact Hours (1.50 hours), CME-Designated Participation Credit (1.50 hours)

Overview

Learning Goals

  1. To review the epidemiology of opioid use disorder (OUD) and the opioid epidemic in the United States
  2. To review the pharmacological properties of fentanyl
  3. To review standard and new approaches to the pharmacological treatment of OUD, including unique considerations for people using fentanyl
  4. To discuss other considerations in the clinical management of people using fentanyl

Presenter
Eugenia Socías, MD, MSc   
Research Scientist/Clinical Research Program Lead: British Columbia Centre on Substance Use
Assistant Professor: Division of AIDS, University of British Columbia Department of Medicine

Learning Outcome
At the conclusion of this learning activity, (at least 75% of) participants will be able to describe at least two fentanyl-specific modifications to standard pharmacological treatment of OUD. 

Disclosure
The following activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for this activity have reported the following financial relationship(s)* with ineligible company(ies)**. All of the relevant financial relationships listed for these individuals have been mitigated.

Lisa Marsch, PhD ~ has stock ownership and royalties/patients for Pear Therapeutics and stock ownership in Square2 Systems.

M. Eugenia Socias, MS, MSc ~ has a research grant from Indivior.

Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this activity report NO financial relationship(s)* with any ineligible company(ies)**.

* A “financial relationship" includes employee, researcher (named as the PI), consultant, advisor, speaker, independent contractor (including contracted research), royalties or patent beneficiary, executive role, and/or an ownership interest (not including stocks owned in a managed portfolio).

** An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Bibliographic Material

  • Ahmad et al. NCHS 2023

  • Coe et al. JAMA 2019

  • Cohen et al. JAMA 2022.

  • Cook. DAD 2022

  • De Aquino et al. Clinical drug investigation 2021

  • Greenwald et al. Annals Emer Med 2022

  • Humphreys et al. Lancet 2022

  • Irvine et al. Addiction 2019

  • Jarvis et al. Addiction 2018

  • Kelly et al. Br J Pharmacol 2021

  • Klimas. BMJ Open 2019

  • Mattick et al. Cochrane Review 2014; Nielsen et al. Cochrane Review 2-22

  • O’Donnell et al. MMWR 2020.

  • O’Donnell et al. MMWR 2021.

  • Pearce et al. BMJ 2020

  • Saulle et al. Cochrane Review 2017

  • Socias et al. Addiction 2022

  • Stone et al. DAD 2019

  • Susuki. DAD 2017

  • Torralva et al. J Pharmacol Exp Ther 2019

  • Varshneya et al. JAM 2021

  • Volpe et al. Regul Toxicol Pharmacol 2011

  • Wakeman et al. JAM 2019

Accreditation

Dartmouth Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Dartmouth Health designates this Enduring Material for a maximum of 1.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Dartmouth Health Nursing Continuing Education Council is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity carries 1.50 contact hour(s).

Registration/Requirements for Successful Completion
You may claim credit for successful completion of this online course. In order to claim credit, you must follow these steps:

  1. Click the Register tab above. If you are not logged into your account, you will need to log in. Use the Forgot Your Password? button if you need to reset your password.
  2. Register for the activity.
  3. Click the Content/Tests tab and then View Content to view the recording. View the entire presentation.
  4. Complete the Post-Test (attestation - return to the Content/Tests tab to find it).
  5. Click My Account in the menu bar; then click Evaluations.
  6. Complete and Submit the Evaluation.

Provider Contact Information
Provider contact information for questions regarding accreditation of the activity:

Center for Learning and Professional Development
CME/CNE Office
Dartmouth Health
[email protected]